Literature DB >> 14987538

[HIV-2 and HTLV-I/II infections in Spain].

Carlos Toro1, Berta Rodés, Antonio Aguilera, Estrella Caballero, Rafael Benito, Sylvina Bassani, Carmen Rodríguez, Concepción Tuset, Raúl Ortiz de Lejarazu, José Eirós, Juan García, Enrique Calderón, Francisco J Capote, Alejandro Vallejo, Maite Gutiérrez, Vicente Soriano.   

Abstract

Up to December 2002, a total of 56, 566 and 109 cases of human T-lymphotropic virus type 1 (HTLV-I), HTLV-II and human immunodeficiency virus type 2 (HIV-2) infection, respectively, were identified in Spain. Most HTLV-I- and HIV-2-infected subjects were immigrants from endemic areas or Spaniards who had traveled to, or had sexual contacts with natives from, these areas. In contrast, HTLV-II infection was mainly limited to Spanish intravenous drug users (IDU) who were frequently coinfected with HIV-1. Among HTLV-I-infected patients, 12 developed subacute myelopathy and 4 adult T-cell leukemia. As for the HIV-2-positive subjects, only 20 (18.3%) developed AIDS. There was no evidence of an increase in the incidence of HIV-2 and HTLV-I infections over time. In contrast, HTLV-II infection has spread in recent years among the HIV-1-positive IDU population in prisons, with a rate of 18% in some regions of Spain. Nevertheless, the prevalence of HTLV-II infection in HIV-1-positive IDU outpatients is still low (4.7%).

Entities:  

Mesh:

Year:  2004        PMID: 14987538     DOI: 10.1157/13058026

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  2 in total

1.  New automated chemiluminescence immunoassay for simultaneous but separate detection of human immunodeficiency virus antigens and antibodies.

Authors:  Roberto Alonso; Paula López Roa; Marisol Suárez; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

2.  Can the level of immunosuppression in human immunodeficiency virus-infected patients affect the reliability of human T-cell lymphotropic virus type 2 serological diagnosis?

Authors:  Sylvina Bassani; Carlos Toro; Victoria Jiménez; Berta Rodés; Vincent Soriano
Journal:  Clin Vaccine Immunol       Date:  2006-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.